Advancing mitochondria as a therapeutic agent: Advancing mitochondria as a therapeutic Agent

Andrés Caicedo, Keshav K. Singh

Producción científica: Contribución a una revistaEditorial

2 Citas (Scopus)

Resumen

This article intends to provide an update of the needs in the field working in the artificial mitochondrial transfer/transplant (AMT/T), and an overview of the highlights from the articles in the special issue “Advances of Mitochondria as a therapeutic agent”. In the last 4 decades, scientists developed innovative therapeutic applications based on the AMT/T, inspired by the natural transfer of mitochondria between cells to repair cellular damage or treat diseases. The clinical application of AMT has become the priority for the field involving the replacement or augmentation of healthy mitochondria in the harmed tissue, especially in the treatment of organ ischemia–reperfusion injury. However, we remark in our article that key questions remain to be answered such which one is the best isolation protocol, tissue or cell source for isolation, and others of great importance to move the field forward.

Idioma originalInglés
Páginas (desde-hasta)33-35
Número de páginas3
PublicaciónMitochondrion
Volumen69
DOI
EstadoPublicada - mar. 2023

Huella

Profundice en los temas de investigación de 'Advancing mitochondria as a therapeutic agent: Advancing mitochondria as a therapeutic Agent'. En conjunto forman una huella única.

Citar esto